| Literature DB >> 31886447 |
H Tankisi1,2, K Pugdahl1,2, S Beniczky1,2, H Andersen3,2, A Fuglsang-Frederiksen1,2.
Abstract
The purpose of this report is to recommend evidence-based strategies for polyneuropathy (PNP) electrodiagnosis based on a large cohort of patients examined prospectively. Nerve conduction studies (NCS) of bilateral tibial, peroneal and sural nerves, the latter with both near-nerve-technique (NNT) and surface recordings, were done in 313 patients with clinically suspected PNP. Bilateral dorsal sural and medial plantar nerves, and unilateral median and ulnar nerves were further examined in a subgroup of patients. The final clinical diagnosis retrieved from the patientś medical records 1-6 years after the neurophysiological investigation served as diagnostic reference standard. The clinical follow-up diagnosis confirmed PNP in 219 patients. The tibial nerve was the most sensitive nerve (75%), with prolonged tibial F-wave as the most sensitive parameter (72%). Sural NNT recordings were more sensitive (66%) than surface recordings (49%) (p < 0.05), however, dorsal sural (68%) and medial planter (70%) nerves had similar sensitivities as NNT. There was no side difference in the incidence of abnormality for any nerve. Based on these results, we recommend a strategy starting with tibial and sural NCS on one side for electrophysiological screening for distal symmetric PNP. If one of these is abnormal, we recommend examining the other lower and upper extremity nerves, including distal sensory nerves, particularly if NNT is not applicable. While one abnormal parameter is sufficient to interpret a nerve as abnormal, we recommend at least two abnormal nerves for PNP diagnosis, preferentially one being the sural nerve. We believe that the strategies recommended in this study may improve PNP electrodiagnosis.Entities:
Keywords: Diagnostic strategy; Evidence-based recommendations; Examination strategy; Nerve conduction studies; Polyneuropathy
Year: 2019 PMID: 31886447 PMCID: PMC6921232 DOI: 10.1016/j.cnp.2019.10.005
Source DB: PubMed Journal: Clin Neurophysiol Pract ISSN: 2467-981X
Fig. 1Electrode placements for A) Dorsal sural and B) Medial plantar nerves.
Demographics of the PNP+ (n = 219) and PNP− (n = 94) groups. Mean value and standard deviation are indicated for continuous parameters. Significant differences (p < 0.05) between the groups are indicated in bold.
| PNP+ | PNP− | PNP+ vs. PNP− | |
|---|---|---|---|
| Age (years) | 58.82 (14.91) | 54.82 (14.77) | |
| Gender (F/M) | 81/138 | 47/47 | |
| Total UENS | 16.48 (7.66) | 4.09 (4.27) | |
| UENS subscores | |||
| Motor | 2.46 (1.92) | 0.43 (1.21) | |
| Small fiber sensation | 6.01 (3.94) | 1.01 (1.62) | |
| Large fiber sensation | 4.86 (2.62) | 1.15 (2.06) | |
| Deep tendon reflexes | 3.19 (1.43) | 1.52 (1.79) |
PNP: Polyneuropathy, F: Female, M: Male, UENS: Utah Early Neuropathy Scale.
Fig. 2Final clinical diagnosis for the patients in the PNP+ and PNP− groups. DM: Diabetes mellitus, CIDP: Chronic inflammatory demyelinating polyneuropathy, HSMN: Hereditary sensory motor neuropathy, GBS: Guillain-Barré syndrome, AIDP: Acute inflammatory demyelinating polyneuropathy, AMAN: Acute motor axonal neuropathy. *B12 deficiency (4), idiopathic (12), renal insufficiency (1), sjogren (1), wegeners granulomatosis (1), DM (1), sifilis (1), amyloidosis (1) chemotherapy induced (2). **renal insufficiency (4), chemotherapy induced (4), multifocal motor neuropathy (3), vasculitic (2), sarcoidosis (2), hypothyroid (1), systemic lupus erythematosus (1), monoclonal gammopathy with unspecific significance (1), mononeuritis multiplex (1) sifilis (1), minor GBS seq. (1), sjogren (1), waldenström (1). ***DM no pnp (1), Kennedy (1), spinal muscular atrophy (1), borrelia seq. (1), myopathy (2), Morton neuralgia (1), claudicatio intermittens (2).
Comparison of NCS parameters on the right and left sides in PNP+ (n = 219) patients.
| Nerve | Parameter | Right Mean (±SD) | Left Mean (±SD) | P-value |
|---|---|---|---|---|
| Peroneal | DML | 5.7 (3.0) | 5.9 (2.2) | 0.381 |
| Motor CV | 38.8 87.1) | 38.6 (7.6) | 0.782 | |
| CMAP amplitude | 4.6 (4.1) | 4.2 (3.6) | 0.388 | |
| F-wave latency | 56.2 (8.1) | 56.5 (8.1) | 0.799 | |
| Tibial | DML | 5.2 (2.1) | 5.3 (1.8) | 0.751 |
| Motor CV | 38.2 (7.7) | 38.4 (7.5) | 0.798 | |
| CMAP amplitude | 9.4 (9.1) | 9.9 (9.3) | 0.606 | |
| F-wave latency | 61.9 (10.0) | 61.9 (11.4) | 0.971 | |
| Sural (surface) | Sensory CV | 48.3 (6.3) | 47.9 (7.3) | 0.582 |
| SNAP amplitude | 7.4 (7.5) | 7.5 (7.4) | 0.959 | |
| Sural (NNT) | Sensory CV | 45.7 (7.7) | 44.5 (7.1) | 0.097 |
| SNAP amplitude | 7.2 (8.8) | 6.3 (7.4) | 0.248 | |
| Dorsal sural | Sensory CV | 43.3 (6.4) | 43.5 (6.8) | 0.859 |
| SNAP amplitude | 3.7 (3.3) | 3.6 (3.0) | 0.953 | |
| Medial plantar | Sensory CV | 49.9 (8.5) | 49.8 (7.9) | 0.329 |
| SNAP amplitude | 5.4 (6.4) | 5.6 (6.2) | 0.900 | |
Fig. 3Percentage of nerves with normal and abnormal nerve conduction studies in 219 patients with clinically confirmed polyneuropathy (PNP+ group). S/M: Sensory/Motor.
Total number of abnormal parameters for each nerve in the PNP+ and PNP− groups.
| Abnormal parameters | |||||||
|---|---|---|---|---|---|---|---|
| Group | Nerves | ≥1 or absent CMAP/SNAP | Absent CMAP/SNAP | ≥1* | ≥2* | ≥3* | ≥4* |
| PNP+ n = 219 | Peroneal | 296 (68%) | 79 (18%) | 217 (61%) | 179 (50%) | 119 (33%) | 54 (15%) |
| Tibial | 330 (75%) | 36 (8%) | 294 (73%) | 204 (51%) | 132 (33%) | 69 (17%) | |
| Sural (surface) | 215 (49%) | 112 (26%) | 103 (32%) | 36 (11%) | – | – | |
| Sural (NNT) | 291 (66%) | 6 (1%) | 285 (66%) | 103 (24%) | – | – | |
| PNP+ n = 681 | Dorsal sural | 93 (68%) | 44 (32%) | 49 (36%) | 28 (21%) | – | – |
| Medial planter | 94 (70%) | 58 (43%) | 36 (27%) | 19 (14%) | – | – | |
| PNP− n = 94 | Peroneal | 28 (15%) | 2 (1%) | 26 (14%) | 5 (3%) | 1 (0.5%) | 1 (0.5%) |
| Tibial | 8 (4%) | 0 | 8 (4%) | 2 (1%) | 0 | 0 | |
| Sural (surface) | 0 | 0 | 0 | 0 | – | – | |
| Sural (NNT) | 3 (2%) | 0 | 3 (2%) | 0 | – | – | |
| PNP− n = 201 | Dorsal sural | 3 (8%) | 0 | 3 (8%) | 0 | – | – |
| Medial planter | 9 (24%) | 0 | 9 (24%) | 1 (3%) | – | – | |
*Absent CMAP or SNAP not included, 1Medial planter nerve was examined in one less patient.
PNP: Polyneuropathy, SNAP: Sensory nerve action potential, CMAP: Compound muscle action potential, NNT: Near nerve technique.
Number of nerves with abnormal parameters in the PNP+ (219 patients) and PNP− (94 patients) groups.
| Group | Nerve | Prolonged DML | Decreased CV | Decreased CMAP/SNAP amplitude | Prolonged or absent minimum F-wave latency |
|---|---|---|---|---|---|
| PNP+ | Peroneal (n = 359) | 96 (27%) | 155 (43%) | 111 (31%) | 209 (58%) |
| Tibial (n = 402) | 106 (26%) | 190 (47%) | 115 (29%) | 290 (72%) | |
| Sural (surface) (n = 326) | – | 40 (12%) | 99 (30%) | – | |
| Sural (NNT) (n = 432) | – | 106 (25%) | 282 (65%) | – | |
| PNP− | Peroneal (n = 186) | 1 (0.5%) | 2 (1%) | 7 (4%) | 23 (12%) |
| Tibial (n = 188) | 0 | 2 (1%) | 1 (0.5%) | 7 (4%) | |
| Sural (surface) (n = 188) | – | 0 | 0 | – | |
| Sural (NNT) (n = 188) | – | 0 | 3 (2%) | – | |
*Numbers indicate the number of nerves, in which the parameter is the only abnormal parameter.
PNP: Polyneuropathy, DML: Distal motor latency, CV: Conduction velocity, SNAP: Sensory nerve action potential, CMAP: Compound muscle action potential, NNT: Near nerve technique.
Numbers in brackets indicate the number of nerves when absent CMAP/SNAP are excluded.
Comparison of abnormal peroneal or sural nerve vs. abnormal tibial or sural nerve. Significant differences are indicated in bold.
| Side | Peroneal or sural | Tibial or sural | McNemar test | |
|---|---|---|---|---|
| PNP+ (219 patients) | Right | 158 | 172 | |
| Left | 157 | 173 | ||
| PNP− (94 patients) | Right | 9 | 6 | p = 0.453 |
| Left | 9 | 2 |
Number of abnormal nerves and parameters for the median and ulnar nerves in patients without carpal tunnel syndrome.
| Abnormal nerves | Absent CMAP/SNAP | Prolonged DML | Decreased CV | Decreased CMAP/SNAP amplitude | Prolonged/absent minimum F-wave latency | |||
|---|---|---|---|---|---|---|---|---|
| PNP+ | Median (n = 175) | 102 (58%) | Motor | 1 | 48 (28%) | 71 (41%) | 23 (13%) | 81 (47%) |
| Sensory | 4 | – | 52 (30%) | 73 (43%) | – | |||
| Ulnar (n = 199) | 115 (58%) | Motor | 0 | 44 (22%) | 75 (38%) | 25 (13%) | 98 (49%) | |
| Sensory | 5 | – | 46 (24%) | 67 (35%) | – | |||
| PNP− | Median (n = 42) | 3 (7%) | Motor | 0 | 0 | 1 (2%) | 1 (2%) | 2 (4%) |
| Sensory | 0 | – | 0 | 1 (2%) | – | |||
| Ulnar (n = 22) | 0 | Motor | 0 | 0 | 0 | 0 | 0 | |
| Sensory | 0 | – | 0 | 0 | – | |||
PNP: Polyneuropathy, CMAP: Compound muscle action potential, SNAP: Sensory nerve action potential, DML: Distal motor latency, CV: Conduction velocity.
Nerves with absent SNAP/CMAP included.
Percentages calculated from the nerves with CMAP/SNAP obtained.